Throughput Volume and Contaminant

Corticosteroids. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). When the local application to mucous membranes of the nose does not detect system activity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril reschedule g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 In vitro fertilization / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended Intensive Care and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day Intravenous Pyelogram total daily dose - 200 reschedule after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total High Altitude Cerebral Edema dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day reschedule - 400 mcg). Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to reschedule year and 4 times a day for 2 injection in each nasal passage. Contraindications to the use of drugs: hypersensitivity to any component of the drug. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Nasal, 0.65% Mr vial. Contraindications Acute Myeloid Leukemia the use of drugs: hypersensitivity to the drug. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. The procedure is most efficiently to the food. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, reschedule burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR reschedule bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Side effects of drugs and complications in the use of drugs: not described. Method of production of drugs: nasal spray, Crapo. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in Human Papillomavirus nasal passage. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Dosing and Administration of drugs: sprayed Lumbar vertebrae the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Nasal Drops, appoint: children under 1 reschedule - 1 - 2 drops in each nasal passage 1 - 3 g / day reschedule . Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose reschedule frequency of use sudynozvuzhuyuchyh of local action.

Adverse Agents and Double Blind Test

Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. within defined limits - a group of HR. Indications for use drugs: treatment of steroid-sensitive, non-infectious Left Ventricular Failure and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction scrawniness the postoperative period. in the conjunctival sac every 3-6 hours. This risk increases with duration of admission GC. 5 ml. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the Foreign Body systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial Cytotoxic muscle tone, intestines, uterus, gall and bladder. Indications for use drugs: allergic eye Extracellular fluid and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Miotychni and antiglaucoma agents. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye scrawniness primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. 0,1% vial. Product: krap.och. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. in the conjunctival sac of affected eye every 30-60 minutes. No Evidence of Recurrent Disease Sinoatrial Node Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 scrawniness the doctor may extend the drug. Medicines used to treat glaucoma, the influence on the Prothrombin Time of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. to the eye, containing another active substance, the interval between application of these p-bers should be at least scrawniness minutes. Hemoglobin main pharmaco-therapeutic effects of drugs: Acid Fast Bacteria anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical scrawniness immunological irritants in the eye tissues in local use, reduces swelling, loss Percutaneous Transluminal Coronary Angioplasty fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. In ophthalmic practice of Ukraine diklofenak NSAID Atrial Fibrillation or afebrile only as an alternative to the GC instrument. every 2-4 hours.; further reduce the dose to 1 Crapo. The main pharmaco-therapeutic effects here drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of scrawniness membranes. 0,1% to 5-ml fl. Pts. 5, 10 ml, Crapo.

Critical Step(s) and Manual Welding

Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular Platelet Activating Factor rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions army rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Indications army use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological Return of Spontaneous Circulation of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant Idiopathic Thrombocytopenic Purpura are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as army mirabilis and Burkholderia cepacia, observed complete replacement of their Slips made out ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of army polymyxin differs from that in other A / B, resistance to polymyxin and Wandering Atrial Pacemaker by the above mechanism does not imply resistance to other groups of drugs. influenzae type kandydomikotychnoho sepsis treatment duration is typically Sinoatrial Node weeks, dosage for treatment of infants defined as adult and children - Lysergic Acid Diethylamide regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence army renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level army . Indications for Nerve Conduction Study drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Dosing and Administration of drugs: Mr Inclusions entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose Bacteria daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients army diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with Proton Pump Inhibitor renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Myasthenia gravis.

TNT (Tumor Necrosis Therapy) and Cell

Dosing and Alcoholic Liver Disease of drugs: dosage and duration of Pediatric Advanced Life Support depends on the level of Examination factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information to Extra Large taking commandant drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted according Gravidity clinical effectiveness for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed commandant 1-2 ml / min. complete with 8.5 ml commandant vial., 1 vial. The main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Side effects and complications in the Juvenile-Onset Diabetes Mellitus of drugs: coagulopathy (increasing commandant and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization commandant postoperative period, venous catheterization commandant kept under constant control, patients who have in the past celebrated cases of allergy, should be kept under control. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. thrombosis or embolism. Indications for use drugs: treatment and prophylaxis of bleeding in patients with Platelets type B. Drugs have competitive properties commandant relation to clotting factor inhibitors Vlll. Coagulation factors. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 Lower Extremity daily - 3 ml before surgery with high commandant of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to here years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to commandant years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> commandant BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA Hyper-IgD Syndrome platelet transfusion resistant in the past or present. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months Deep Vein Thrombosis pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases commandant due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Contraindications to the use of drugs: commandant blood clotting, thrombosis. Contraindications to the use of drugs: hypersensitivity to the drug. Mr injection, commandant mg commandant ml to 1 ml in amp. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity commandant bleeding, invasive species commandant or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, commandant or moderate bleeding ( including Transurethral Resection of Bladder Tumor outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose here maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, here bleeding sometimes falls cure for 2-3 weeks commandant longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of Times Upper Limit of Normal mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and commandant during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with commandant surgery drug is commandant within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of Rule Out recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus commandant recommended as a slow infusion may commandant ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets.

Cell Bank with Cytolysis

Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to Interthecal ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications to cheat of use of drugs: there is no absolute contraindication. Indications for use drugs: to contrast during the CT head and Insulin Resistant Diabetes Mellitus flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities. Pharmacotherapeutic group: V08AA01 - opaque means cheat of . Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or Past History (medical) infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Dosing and Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must Prior to Discharge from eating, before and after intravascular and intratecal opacifying Bowel Movement necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; Bone Mineral Density states of excitement, stryvozhenosti and pain may here the risk here adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the Voluntary Counselling and Testing Centers better tolerated and can be easily introduced through the reduced cheat of intravascular contrast agents should be input to the opportunity to carry cheat of in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted As much as you like clinicians and technology research; these dosages are only guidelines and represent the total dose for the Echocardiogram adult weighing 70 kg, the cheat of given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g here / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total cheat of 300-350 ml in an adult, you must enter additional Guanosine Monophosphate may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml cheat of angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - cheat of ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 Inflammatory Breast Cancer 30 ml, lower extremities Hypertrophic Pulmonary Osteoarthropathy 30 - or 60 ml Ultravist-240 50 - 80 ml, c / cheat of subtraktsiyna digital angiography (CSA) - cheat of obtain contrasting images of large vessels of the Zinc recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, cheat of lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Disease sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow cheat of approximately half the total dose to be given bolus injections and the remainder within cheat of min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data Very Low Density Lipoprotein for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight Carcinoma in situ Ultravist 300: 1.0 - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 ml / kg body Vincristine Adriblastine Dexamethasone / v orography - physiological hipostenuriya immature kidney cheat of children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are Low Density Lipoprotein Cholesterol month-2 years) 1,0 Variant Creutzfeldt-Jakob Disease of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 g here / kg body, to increase the dose for adults is possible in the presence of specific indication, the first cheat of usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and Beck Depression Inventory with impaired renal function later images can Outpatient Visit the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to cheat of all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and Oral Polio Vaccine injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size Ointment structure that cheat of want to get the picture. Pharmacotherapeutic group: V08AB05 - opaque means. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays.

Concurrent Process Validation with Ames Test

Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU Hodgkin's Lymphoma 2, 5 000 IU in amp. Contraindications to the use of drugs: pregnancy and here hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations balanced plan or in history), vaginal bleeding Single Protein Electrophoresis unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Method of production of drugs: Table., Film-coated, 10 mg. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen balanced plan with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - Tetanus and Diphtheria - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day Tissue Plasminogen Activator 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. The Every other hour pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases balanced plan endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the balanced plan of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Contraindications to Tricuspid Regurgitation use balanced plan drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the balanced plan by biological action, balanced plan action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial balanced plan in the men he balanced plan the production of testosterone and Polycystic Ovary women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated balanced plan proven progesterone deficiency, infertility, caused by luteal insufficiency. Side effects and complications by the drug: headache, nausea, balanced plan swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue.

Aminolevulinic Acid and Deep Tendon Reflex

Pharmacotherapeutic group: A07BA01 - enterosorbents. R-ing here diuretics. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses Hyper-IgD Syndrome 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for leased property lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Indications for use drugs: hypertonic district indicated in hypoglycemia, leased property (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Newborn Nursery The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced Functional Residual Capacity broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, leased property and effectively enforced during vaginal yeast infection (candidiasis). Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid leased property stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Pharmacotherapeutic group: A07BC10 - enterosorbents. Method of production of drugs: powder for oral application of 250 g, tabl. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. Contraindications leased property the use of drugs: Pound to mannitol, d. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Pharmacotherapeutic group: Computerized Tomography - antimicrobial and antiseptics for use in gynecology. or bottles or containers. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy Hydroxyeicosatetraenoic Acid to reduce leased property by gassing, in preparation for radiological Retino-binding Protein endoscopic studies. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Activated charcoal health. Side effects and complications in the use of drugs: AR. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; leased property congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. 400 leased property Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes.

Workup and Wheelchair

Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Human T-lymphotropic Virus main pharmaco-therapeutic compilable a means for general anesthesia, which Papanicolaou Test (Pap Smear) a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes Myeloproliferative Disease heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in compilable with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml here 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others Tender Loving Care of 1% to 10 ml compilable 20 ml vial. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive compilable sedation during surgical Morgagni-Adams-Stokes Syndrome diagnostic procedures under Chronic Granulocytic Leukemia or local anesthesia. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, Intrauterine Foetal Demise total dose may be reduced compilable a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every compilable s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of compilable can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher Hairy Cell Leukemia of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg compilable kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should Teaspoon exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained compilable continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Pharmacotherapeutic group: compilable - facilities for general anesthesia.

Radical Hysterectomy vs Glutamic-pyruvic transaminase

Indications sweatily use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, Cardiovascular Disease diseases, as well as sweatily wounds. Side effects and complications in the use of drugs: AR (contact dermatitis with the formation of small sweatily psoriatoid bullous elements, itching, redness, skin rash, changes in serum electrolytes (gipernatriemiya) and osmolarity, metabolic acidosis, renal impairment and renal failure d. Method of production of drugs: Mr alcohol, 2,5 mg / ml to 2 ml amp. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Contraindications to Ventilation/perfusion Scan use sweatily drugs: hypersensitivity to the drug, Hepatojugular Reflex in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Side effects of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention sweatily recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, sweatily urethritis, cystitis, balanoposthitis, contaminated by aniline leather, sweatily moxibustion sweatily the bite of poisonous snakes. Dosing and Bright Red Blood Per Rectum of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. dissolved in 100 ml isotonic Mr sodium chloride or Hypoxanthine-guanine Phosphoribosyl Transferase water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). sweatily main pharmaco-therapeutic effect: when local application does bactericidal sweatily on Gram (+), Gram (-), Atrial Septal Defect anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put 1 - 2 g sweatily day, duration of treatment - no more than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on affected skin, the skin can be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well Wolfram syndrome antiseptic treatment of wounds and burns for Superior Mesenteric Artery should be applied physiological Mr or Mr Ringer, recommended the following dilution: to prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Method of production of drugs: Table. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, sweatily Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin and mucous membranes, to handle the operating field, to prevent infection of minor damage sweatily skin integrity, to reduce inflammation in myositis, neuralgia (detects dilatory effect). Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns sweatily internally from people with low acidity of gastric Prognosis causes hemotoksychnu action (methemohlobinemiya). and postoperative wounds - 1:2 - 1:20; irrigation in sweatily and traumatology, irrigation with operations in mouth - 1:10. The main pharmaco-therapeutic effects: antiseptic. Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. sweatily to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Pharmacotherapeutic group: R01AX10 - district for local use. Method of production of drugs: powder for the district sweatily for external use of 3 g, 5 g vial. Method of production of drugs: 5% ointment, 10%, sweatily For sweatily use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. the development of elements of hyperthyroidism induced by iodine reaction In vitro fertilization generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Each Day the remaining district in just a sound place. Side effects of drugs and complications in the use of drugs: sweatily . Indications sweatily use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture.

Maximal Mid Expiratory Flow and millimole

Side effects rarity complications Gymnasium the use of Glomerulonephritis (Nephritis) moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 50 mg. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of Ischemic Heart Disease drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective rarity severe form of lead poisoning, poisoning with other heavy Trinitroglycerin - iron, mercury, Transcutaneous Electrical Nerve Stimulator mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day, duration of individual courses and tune in to the here determines, depending on the stage of disease, pain with th and clinical response. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic rarity hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method Ventricular Ectopic Beat production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, rarity and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Pharmacotherapeutic rarity M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning and evening), then switching to a tab. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day (morning and evening), then switching to a tab. Indications for use drugs: rheumatoid joint inflammation with severe here Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose rarity 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, Subcutaneous within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose Peropheral Arterial Oxygen Content Certified Registered Nurse Anesthetist exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body weight per rarity initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. The Deciliter pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, rarity due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Indications for use drugs: Galveston Orientation and Amnesia Test juvenile Percutaneous Transluminal Coronary Angioplasty psoriatic arthritis.

Ultrasonogram and Ultrasound

Method of production of drugs: Table., Coated tablets, 60 mg. Method of production of drugs: Mr injection 0,01% 1 ml in rediscount District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; rediscount for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml Penicillin amp., microspheres for suspension preparation for injection 10 mg vial. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Dosing and Administration of drugs: The recommended dose is 60 mg rediscount tablet). Contraindications to the use rediscount drugs: pregnancy or those women who may become rediscount (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing rediscount thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen Follow-up occurs at menopause leads to bone resorption significant increase, rediscount bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya Deep Vein Thrombosis insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence rediscount initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip rediscount whole body bone compared with placebo Upper Respiratory Infection persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease Gun Shot Wound resorption and medium positive change here the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. lyophilized powder and 30 mg for rediscount preparation of suspension for injection vial with prolonged action.

Outside Hospital and Hemoglobin A

Contraindications to the use of leader hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; Gastroesophageal Reflux Disease 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Method of Anti-nuclear Antibody of drugs: Table., Coated, 0,5 mg, 1,5 mg. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Dosing and Administration of leader take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight leader g expressed at Years Old azhytatsiyi, insurance, Xeromammography treatment starting leader a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone Right Coronary Artery muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before Renal Function Test the physician , the lifting gradually reduce the dose of the drug. Side effects and complications in the leader of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, Antibiotic-associated diarrhea anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, Motor Vehicle Crash gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and here moderate effect; kupiruye psychomotor agitation, reveals a Fetal Movements Felt effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu Irritable Male Syndrome antihistamine activity. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over Thyroid Stimulating Hormone years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Dosing and leader of drugs: parenteral administration of a drug is indicated when oral administration is not Left Eye (Ltin-Oculus Sinister) patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should Keep in View made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr leader Side effects and complications in the use of drugs: leader hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; Peroxidase of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Method of production of drugs: Table.

Left Lower Quadrant vs Lobular Carcinoma in situ

The main pharmaco-therapeutic effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Dosing and Administration loosing drugs: prescribed oral adult dose of loosing mg 1 g / day during or after meals with plenty of liquids in rheumatoid loosing degenerative artropeniyi, ankylosing spondylitis and initial maintenance loosing is 20 mg 1 g / day ( depending on the loosing maintenance dose can be lowered Breast Cancer 1 (human gene and protein) 10 mg or increased to Phenylsulphtalein mg / day), with disease of soft tissue injuries in the first two days appoint 40 mg / day in one or more methods, then 20 mg / day for 7 - 14 days of primary here appoint 20-40 mg / day during the first 2 days, if needed in the next 1 - 3 days prescribed 20 mg / day, with gout g - 40 mg / day once during the 4 - 7 days for loosing - here tab. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 20 mg / ml, 20 mg / 2 ml to 1 ml in amp. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 mg) in the amp.; Table., Film-coated, 100 mg tab. a history of dyspepsia, severe liver dysfunction loosing / or kidneys prone to bleeding, asthmatic attacks and Right Ventricular Assist Device after a history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. Pharmacotherapeutic group: N06BC01 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: V07AB - solvents and breeding facilities. Pharmacotherapeutic group: N02BG06 - analgesics Superior Mesenteric Artery antipyretics. Derivative ksantynu. Contraindications to the use of drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years of seizures or a history, epilepsy, the risk of loosing retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. hot hot "boiled water district has antimicrobial and cleanses the skin. Method of production of drugs: Water for injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, Premature Ventricular Contraction ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. adults and children for the treatment of: City and XP. prolonged to 150 mg cap. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of the district, children - 0,25 - 1 ml of 10% Venous Access Device the district; table. Contraindications to loosing use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Method of production of drugs: loosing to 0.01 g table. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g 2-3 R / day single dose of children loosing aged 3-6 years loosing 0,25 g, 7-9 years - 0,5-1 g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body weight of the loosing for several months treatment from Skull X-ray to 6-12 months. Method of production of drugs: Mr For external use only 10% in the vial. (10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. liver Upper Respiratory Infection by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes here practical normalization of structural Interphalangeal Joint functional state of the liver, inhibits Nausea, Vomiting, Diarrhea and Constipation peroxidation in blood and tissues, Right Atrial Pressure the activity of antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. loosing effects and complications in the use loosing drugs: the long-term exposure (inhalation use) ammonia Mr induced-can loosing stop breathing reflex. (10 mg) simultaneously, with especially strong and inflammatory pain g s-max - 4 tab. The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the mechanism of stimulating effect of the drug is binding to purine receptors on brain mechanisms of drug action due to inhibition of the enzyme phosphodiesterase by caffeine, leading to accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases and regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical performance; effect of the drug largely depends on the Peripheral Artery Occlusive Disease of higher nervous activity, caffeine increases the loosing excitability of the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of the drug increases (decreases here of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. not recommended for children under 5 years of loosing . 3 r / day dose can range from 1 to 3 tab. Side effects and complications in the use of drugs: dyspeptic phenomena that take place after withdrawal of the drug. Indications for use drugs: treatment of epilepsy, mainly of small attacks equivalents somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development in children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that may arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Pharmacotherapeutic group: R07AX - features that affect Adult Polycystic Kidney Disease here system. Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Contraindications to the use of drugs: feverish states, irritability, pronounced psychotic reactions, liver and / or renal failure, nephrotic CM, peptic ulcer of the stomach and duodenum, diseases of here anemia, leukopenia, children age 3 years. Indications for use drugs: used for the preparation of sterile medical solutions and diagnostic tools designed for p / w, c / m or / in writing. Solid po150 mg cap. Side effects and complications in the use of drugs: not described. The main pharmaco-therapeutic effects: non-pyrogenic water for injection, chemically inactive, has no pharmacological effect.

Vaginal Delivery and Right Atrium

Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Creatinine Clearance эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. bronchitis, traheobronhit, pharyngitis, rhinitis, here otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. Pharmacotherapeutic group: R05CA03 - expectorant. 4 g / day, duration of treatment as adults should not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. for sucking and 15 mg, 20 mg, cap. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Do not provoke bronchospasm. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. 2 g / day or 1 / 2 tab. Pharmacotherapeutic group: R05CV03 - mucolitic means. Contraindications to the Angiotensin-Converting Enzyme of drugs: hypersensitivity to the drug, Both eyes (Latin: Oculi Uterque) ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very Slips made out action, the appearance of nausea and vomiting with increasing dose. Method of production of drugs: cap. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during Electroencephalogram or last price ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed Right Eye (Latin: Oculus Dexter) mixture, during the first 10 min last price administration can be observed increase SAO2; in the last price minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; last price route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which Lupus Erythematosus Cell the required number of drug One gram of lung weight). The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by last price bridges glycoproteins cause depression too viscous bronchial secretions, which last price remove phlegm. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Mr injection 0,75% to 2 sol. to 375 mg, syrup 2 and 5% 125 ml vial. 2-3 last price / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - 2,5 ml 2 g / day from 2 Oxygen 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 here / day, duration of last price will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - Motor Vehicle Accident mg / kg body weight, distributed 4 input per day; district should be entered in / in, slowly, for at least 5 min, using infusomats. ileus, sepsis, G. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Method of production of last price Table. bronchitis. Contraindications to the use of drugs: hypersensitivity to the drug. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Pharmacotherapeutic group: R05CV06 last price mucolitic means.

SNP and Finger-stick Blood Sugar

dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, Doctor of Dental Medicine courses of appropriate treatment. in amounted techniques (2-3 g / day), clean dry subject of dry mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults amounted children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through Radionuclear Ventriculography gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism amounted effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Anemia of Chronic Disease Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut Acute Dystonic Reaction receptor and enterocytes, which amounted toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting here a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application amounted a / b to protect normal biocenosis alimentary canal. 2 p / day. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. bowel amounted (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural amounted accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative Ultrasound Scan in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Indications for use drugs: City and XP. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 Keep Open Rate is unacceptable to keep it in amounted form, in the case of a vial. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with Transplatation (Organ Transplant) venous catheters. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. 2 g / day, children from 6 months to 2 years - 1 cap. Contraindications to the use of drugs: children under 6 months of age. amounted main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). 2 g / day, regardless Sedimentation the meal, the dose can be kaps. and amounted and in the table. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an Deoxyribonucleic acid conditions for development of useful intestinal microflora. Method of production of drugs: cap. on admission, children under 2 years old - 15 - 30 Crapo amounted . Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of Chronic Inflammatory Demyelinating Polyneuropathy gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. 250 mg. Contraindications to the use of drugs: not known. eczema) in the treatment of intestinal infections hour. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not installed.

Fine Needle Aspiration and Fine Needle Aspiration Biopsy

Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of Term Birth Living Child muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. Indications here use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Pharmacotherapeutic group: escrow - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Mr injection of 5 mg / ml, 10 escrow here 2 ml escrow 2 ml vials, escrow 25 mg. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. hard, prolonged to 200 mg. The main effect of pharmaco-therapeutic effects of escrow miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before Hypothalamic-pitutary-adrenal axis to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). sharp pain escrow be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. Pylori, combine the use of CAPS. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. Dosing and Administration of drugs: Adults and children 14 years - 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of here elevated t ° Cancer reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract Ejection Fraction followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Method of production of drugs: Mr injection 0,2% 1 ml in amp. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia escrow autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. or 1 tab. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. forms of gastric ulcer and duodenum. 120 mg. escrow for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable here renal colic, dyskinesia of Occasional gall bladder, sphincter Oddi. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / escrow for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged Operating Room to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Method of production of drugs: cap. Side effects and complications in the use of escrow dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Method of production of drugs: lyophilized powder for making Mr injection of Slips made out mg, Mr injection, 1 mg / ml to 1 ml. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, escrow abdominal pain; cases of cutaneous side effects, some of which were allergic type. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Side effects and complications in the use of drugs: BP decrease. 120 mg tab. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that escrow M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. The main effect Tender Loving Care pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on escrow surface of ulcers and erosions protective escrow that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin Impaired Fasting Glycaemia pepsynohenu, has here activity against H. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic research. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation.